Roger
1,000+ Posts
my concern isn't that pfizer is going to walk away from the US market. My concern is more that right now the US is exclusively making research for a company like pfizer viable. Thus if the US basically says we are only going to pay 25% of your asking price, is there enough incentive for Pfizer to continue to do R&D for new drugs? Currently the time period of exclusivety on a drug is their chance to get that R&D money back.
Thus I see 2 possible scenario's 1) the R&D dries up and or 2) the cost of these drugs globally will have to rise in order for the cost in the US to go down, thus the price will have to come close to a equalization globally.
Thus I see 2 possible scenario's 1) the R&D dries up and or 2) the cost of these drugs globally will have to rise in order for the cost in the US to go down, thus the price will have to come close to a equalization globally.